Clinical Trials Browser

Phase 3 × Bronchiolitis Obliterans Syndrome × Dasatinib × Clear all

NCT01460693 2018-04-24

SPIRIT2

Phase 3 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myeloid, Chronic-Phase